Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents.

Saved in:
Bibliographic Details
Title: Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents.
Authors: Kangro K; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Kurašin M; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Gildemann K; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Sankovski E; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Žusinaite E; Institute of Technology, University of Tartu, Tartu, Estonia., Lello LS; Institute of Technology, University of Tartu, Tartu, Estonia., Pert R; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Kavak A; Department of Clinical Veterinary Medicine, Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, Tartu, Estonia., Poikalainen V; Teadus ja Tegu OÜ, Märja, Tartumaa, Estonia., Lepasalu L; Teadus ja Tegu OÜ, Märja, Tartumaa, Estonia., Kuusk M; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Pau R; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Piiskop S; Chemi-Pharm AS, Tänassilma, Harjumaa, Estonia., Rom S; Chemi-Pharm AS, Tänassilma, Harjumaa, Estonia., Oltjer R; Chemi-Pharm AS, Tänassilma, Harjumaa, Estonia., Tiirik K; Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia., Kogermann K; Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia., Plaas M; Institute of Biomedicine and Translational Medicine, Laboratory Animal Centre, University of Tartu, Tartu, Estonia., Tiirats T; Department of Clinical Veterinary Medicine, Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, Tartu, Estonia., Aasmäe B; Department of Clinical Veterinary Medicine, Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, Tartu, Estonia., Plaas M; Ear Clinic of Tartu University Hospital, Tartu, Estonia., Mumm K; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Krinka D; Icosagen AS, Õssu, Kambja vald, Tartumaa, Estonia., Talpsep E; Icosagen AS, Õssu, Kambja vald, Tartumaa, Estonia., Kadaja M; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Gerhold JM; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Planken A; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia.; North-Estonian Medical Centre, Tallinn, Estonia., Tover A; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Merits A; Institute of Technology, University of Tartu, Tartu, Estonia., Männik A; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Ustav M Jr; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia., Ustav M; Icosagen Cell Factory OÜ, Õssu, Kambja vald, Tartumaa, Estonia.
Source: PloS one [PLoS One] 2022 Jun 10; Vol. 17 (6), pp. e0268806. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0268806